Table 4 |
|||
|
Reported cases of Dapsone Hypersensitivity Syndrome with pulmonary manifestations. |
|||
| Age/Sex |
Pulmonary manifestations |
Treatment |
Reference |
|
|
|||
| 22/M' |
Crepitations |
DW*, Steroid |
(6) |
| 47/F |
Pulmonary eosinophilia |
DW, Steroid |
(11) |
| 65/F |
Pulmonary eosinophilia |
DW |
(12) |
| 45/M |
Pulmonary eosinophilia |
DW, Steroid |
(13) |
| 60/F |
Eosinophilic pneumonia |
DW |
(14) |
| 23/F |
Eosinophilic pneumonia |
DW, Steroid |
(15) |
| 31/M |
Eosinophilic pneumonia with pulmonary infarction |
DW, Steroid |
(15) |
| 37/F |
Eosinophilic pneumonia |
DW |
(15) |
| 40/F" |
Hypersensitivity pneumonitis |
DW, Steroid |
(16) |
| 15/M |
Right sided pleural effusion |
DW, Steroid |
(17) |
|
|
|||
|
*DW means drug withdrawal with supportive therapy only. ' M = male, " F = female. |
|||
|
Kosseifi et al. Journal of Occupational Medicine and Toxicology 2006 1:9 doi:10.1186/1745-6673-1-9 |
|||
